Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

PhRMA Medication Error Reduction Plan Slated For July Release

  • News

Executive Summary

The Pharmaceutical Research & Manufacturers of America expects to have recommendations on reducing medication errors for member companies by early summer.

You may also be interested in...



Bar Code Labels With NDC Numbers Possible In 2-3 Years, PhRMA Predicts

Pharmaceutical manufacturers could include National Drug Code numbers in bar code labels within two to three years, the Pharmaceutical Research & Manufacturers of America said

Bar Code Labels With NDC Numbers Possible In 2-3 Years, PhRMA Predicts

Pharmaceutical manufacturers could include National Drug Code numbers in bar code labels within two to three years, the Pharmaceutical Research & Manufacturers of America said

Off Label Drug Use Data To Be Required In Periodic Safety Updates - FDA

Pharmaceutical companies will be asked to provide postmarketing drug usage information in their periodic safety update reports, including use in off label indications, under a proposed FDA rule due out later this year.

Table

View full table

Related Content

Pink Sheet
Tags:
Latest Headlines

Pharma Can Pursue Claims Against Providers For 340B Duplicate Discounts In Medicaid Managed Care, HRSA Says

The Aspirin Test For AI?

Mary Beth Clarke, CDER Exec Programs Office Director And Generic User Fee Shepherd, Will Retire

Rx Advertising: Interchangeability Doesn’t Mean Clinical Superiority To Other Biosimilars, FDA Says

See All
UsernamePublicRestriction

Register

PS035736

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By